|
|
pancreas morphogenesis
|
GO:0061113 |
3 |
0.586
|
|
|
|
pancreas development
|
GO:0031016 |
57 |
0.475
|
|
|
|
exocrine pancreas development
|
GO:0031017 |
7 |
0.475
|
|
|
|
transmission of nerve impulse
|
GO:0019226 |
76 |
0.445
|
|
|
|
ossification
|
GO:0001503 |
216 |
0.444
|
|
|
|
fertilization
|
GO:0009566 |
127 |
0.436
|
|
|
|
cellular amino acid metabolic process
|
GO:0006520 |
103 |
0.423
|
|
|
|
regulation of cellular amine metabolic process
|
GO:0033238 |
20 |
0.415
|
|
|
|
protein maturation
|
GO:0051604 |
176 |
0.407
|
|
|
|
protein processing
|
GO:0016485 |
163 |
0.400
|
|
|
|
digestion
|
GO:0007586 |
40 |
0.361
|
|
|
|
skin development
|
GO:0043588 |
220 |
0.353
|
|
|
|
neuronal action potential
|
GO:0019228 |
54 |
0.327
|
|
|
|
regulation of ion transport
|
GO:0043269 |
215 |
0.306
|
|
|
|
cellular amine metabolic process
|
GO:0044106 |
44 |
0.287
|
|
|
|
exocrine system development
|
GO:0035272 |
45 |
0.249
|
|
|
|
regulation of protein kinase activity
|
GO:0045859 |
232 |
0.248
|
|
|
|
macromolecule catabolic process
|
GO:0009057 |
281 |
0.227
|
|
|
|
regulation of transferase activity
|
GO:0051338 |
263 |
0.214
|
|
|
|
action potential
|
GO:0001508 |
78 |
0.207
|
|
|
|
negative regulation of cellular amine metabolic process
|
GO:0033239 |
1 |
0.204
|
|
|
|
cellular amide metabolic process
|
GO:0043603 |
58 |
0.196
|
|
|
|
ensheathment of neurons
|
GO:0007272 |
76 |
0.194
|
|
|
|
negative regulation of phosphate metabolic process
|
GO:0045936 |
184 |
0.188
|
|
|
|
regulation of cellular amino acid metabolic process
|
GO:0006521 |
5 |
0.185
|
|
|
|
negative regulation of cell development
|
GO:0010721 |
169 |
0.181
|
|
|
|
digestive system development
|
GO:0055123 |
200 |
0.178
|
|
|
|
ion transmembrane transport
|
GO:0034220 |
361 |
0.177
|
|
|
|
striated muscle contraction
|
GO:0006941 |
45 |
0.168
|
|
|
|
regulation of ion transmembrane transport
|
GO:0034765 |
119 |
0.166
|
|
|
|
skeletal system development
|
GO:0001501 |
356 |
0.166
|
|
|
|
transmembrane transport
|
GO:0055085 |
412 |
0.166
|
|
|
|
erk1 and erk2 cascade
|
GO:0070371 |
77 |
0.159
|
|
|
|
regulation of transmembrane transport
|
GO:0034762 |
128 |
0.158
|
|
|
|
negative regulation of phosphorus metabolic process
|
GO:0010563 |
184 |
0.157
|
|
|
|
peptidyl tyrosine phosphorylation
|
GO:0018108 |
143 |
0.156
|
|
|
|
gland development
|
GO:0048732 |
330 |
0.151
|
|
|
|
regulation of tube size
|
GO:0035150 |
57 |
0.149
|
|
|
|
regulation of membrane potential
|
GO:0042391 |
192 |
0.147
|
|
|
|
organonitrogen compound biosynthetic process
|
GO:1901566 |
192 |
0.145
|
|
|
|
zymogen activation
|
GO:0031638 |
41 |
0.145
|
|
|
|
purine nucleotide biosynthetic process
|
GO:0006164 |
65 |
0.142
|
|
|
|
myelination
|
GO:0042552 |
74 |
0.141
|
|
|
|
vasodilation
|
GO:0042311 |
28 |
0.137
|
|
|
|
sterol homeostasis
|
GO:0055092 |
45 |
0.136
|
|
|
|
regulation of lipid metabolic process
|
GO:0019216 |
118 |
0.135
|
|
|
|
cellular nitrogen compound catabolic process
|
GO:0044270 |
280 |
0.134
|
|
|
|
negative regulation of neuron differentiation
|
GO:0045665 |
101 |
0.133
|
|
|
|
heart contraction
|
GO:0060047 |
93 |
0.133
|
|
|
|
peptidyl amino acid modification
|
GO:0018193 |
336 |
0.128
|
|
|
|
regulation of metal ion transport
|
GO:0010959 |
106 |
0.124
|
|
|
|
immune effector process
|
GO:0002252 |
321 |
0.118
|
|
|
|
lipoprotein metabolic process
|
GO:0042157 |
43 |
0.117
|
|
|
|
negative regulation of protein metabolic process
|
GO:0051248 |
282 |
0.117
|
|
|
|
negative regulation of cellular amino acid metabolic process
|
GO:0045763 |
0 |
0.115
|
|
|
|
cardiac muscle contraction
|
GO:0060048 |
32 |
0.114
|
|
|
|
positive regulation of map kinase activity
|
GO:0043406 |
84 |
0.112
|
|
|
|
positive regulation of cellular amino acid metabolic process
|
GO:0045764 |
3 |
0.109
|
|
|
|
cell fate determination involved in pattern specification
|
GO:0060582 |
1 |
0.108
|
|
|
|
negative regulation of neuron projection regeneration
|
GO:0070571 |
3 |
0.106
|
|
|
|
endocrine system development
|
GO:0035270 |
98 |
0.103
|
|
|
|
single fertilization
|
GO:0007338 |
82 |
0.103
|
|
|
|
negative regulation of protein modification process
|
GO:0031400 |
163 |
0.103
|
|
|
|
sperm egg recognition
|
GO:0035036 |
37 |
0.101
|
|
|
|
regulation of anatomical structure size
|
GO:0090066 |
178 |
0.099
|
|
|
|
regulation of mapk cascade
|
GO:0043408 |
248 |
0.099
|
|
|
|
positive regulation of transcription via serum response element binding
|
GO:0010735 |
1 |
0.098
|
|
|
|
regulation of cellular response to stress
|
GO:0080135 |
159 |
0.096
|
|
|
|
negative regulation of cellular component organization
|
GO:0051129 |
194 |
0.095
|
|
|
|
carbohydrate derivative biosynthetic process
|
GO:1901137 |
183 |
0.095
|
|
|
|
positive regulation of cellular amine metabolic process
|
GO:0033240 |
5 |
0.094
|
|
|
|
regulation of epithelial cell proliferation
|
GO:0050678 |
141 |
0.093
|
|
|
|
lipid transport
|
GO:0006869 |
98 |
0.092
|
|
|
|
negative regulation of intracellular signal transduction
|
GO:1902532 |
167 |
0.091
|
|
|
|
lung development
|
GO:0030324 |
164 |
0.091
|
|
|
|
negative regulation of phosphorylation
|
GO:0042326 |
166 |
0.088
|
|
|
|
cellular ketone metabolic process
|
GO:0042180 |
84 |
0.086
|
|
|
|
multicellular organismal signaling
|
GO:0035637 |
91 |
0.086
|
|
|
|
peptide metabolic process
|
GO:0006518 |
46 |
0.086
|
|
|
|
second messenger mediated signaling
|
GO:0019932 |
73 |
0.086
|
|
|
|
negative regulation of cell proliferation
|
GO:0008285 |
296 |
0.085
|
|
|
|
sterol transport
|
GO:0015918 |
38 |
0.085
|
|
|
|
endochondral bone morphogenesis
|
GO:0060350 |
50 |
0.084
|
|
|
|
apoptotic signaling pathway
|
GO:0097190 |
306 |
0.083
|
|
|
|
mesenchyme development
|
GO:0060485 |
152 |
0.083
|
|
|
|
regulation of voltage gated calcium channel activity
|
GO:1901385 |
4 |
0.081
|
|
|
|
angiogenesis
|
GO:0001525 |
201 |
0.081
|
|
|
|
smoothened signaling pathway
|
GO:0007224 |
105 |
0.080
|
|
|
|
respiratory tube development
|
GO:0030323 |
167 |
0.078
|
|
|
|
cardiac chamber development
|
GO:0003205 |
108 |
0.077
|
|
|
|
regulation of peptidyl tyrosine phosphorylation
|
GO:0050730 |
93 |
0.076
|
|
|
|
muscle contraction
|
GO:0006936 |
101 |
0.076
|
|
|
|
oxidation reduction process
|
GO:0055114 |
342 |
0.076
|
|
|
|
small gtpase mediated signal transduction
|
GO:0007264 |
97 |
0.075
|
|
|
|
heart morphogenesis
|
GO:0003007 |
178 |
0.075
|
|
|
|
regulation of kinase activity
|
GO:0043549 |
249 |
0.074
|
|
|
|
regulation of body fluid levels
|
GO:0050878 |
162 |
0.074
|
|
|
|
heart process
|
GO:0003015 |
94 |
0.072
|
|
|
|
cell adhesion
|
GO:0007155 |
329 |
0.072
|
|
|
|
cartilage development
|
GO:0051216 |
140 |
0.071
|
|
|
|
extracellular structure organization
|
GO:0043062 |
148 |
0.071
|
|
|
|
ribonucleotide metabolic process
|
GO:0009259 |
291 |
0.071
|
|
|
|
aromatic compound catabolic process
|
GO:0019439 |
286 |
0.071
|
|
|
|
tissue remodeling
|
GO:0048771 |
102 |
0.071
|
|
|
|
epithelial tube morphogenesis
|
GO:0060562 |
303 |
0.069
|
|
|
|
regulation of store operated calcium entry
|
GO:2001256 |
4 |
0.069
|
|
|
|
odontogenesis
|
GO:0042476 |
78 |
0.068
|
|
|
|
negative regulation of cellular protein metabolic process
|
GO:0032269 |
247 |
0.068
|
|
|
|
protein catabolic process
|
GO:0030163 |
221 |
0.067
|
|
|
|
regulation of hydrolase activity
|
GO:0051336 |
246 |
0.067
|
|
|
|
morphogenesis of a branching epithelium
|
GO:0061138 |
193 |
0.066
|
|
|
|
regulation of defense response
|
GO:0031347 |
233 |
0.065
|
|
|
|
regulation of neuron projection development
|
GO:0010975 |
169 |
0.063
|
|
|
|
atrial ventricular junction remodeling
|
GO:0003294 |
2 |
0.063
|
|
|
|
fat cell differentiation
|
GO:0045444 |
160 |
0.063
|
|
|
|
positive regulation of protein modification process
|
GO:0031401 |
299 |
0.063
|
|
|
|
cholesterol metabolic process
|
GO:0008203 |
56 |
0.063
|
|
|
|
embryonic skeletal system development
|
GO:0048706 |
120 |
0.063
|
|
|
|
response to organonitrogen compound
|
GO:0010243 |
246 |
0.063
|
|
|
|
positive regulation of vasoconstriction
|
GO:0045907 |
4 |
0.062
|
|
|
|
regulation of lipoprotein metabolic process
|
GO:0050746 |
4 |
0.062
|
|
|
|
cellular lipid metabolic process
|
GO:0044255 |
323 |
0.061
|
|
|
|
regulation of ossification
|
GO:0030278 |
112 |
0.059
|
|
|
|
positive regulation of kinase activity
|
GO:0033674 |
155 |
0.059
|
|
|
|
foramen ovale closure
|
GO:0035922 |
1 |
0.058
|
|
|
|
negative regulation of macrophage activation
|
GO:0043031 |
2 |
0.057
|
|
|
|
negative regulation of cytokine production
|
GO:0001818 |
84 |
0.056
|
|
|
|
clara cell differentiation
|
GO:0060486 |
4 |
0.056
|
|
|
|
cholesterol transport
|
GO:0030301 |
38 |
0.055
|
|
|
|
defense response to other organism
|
GO:0098542 |
197 |
0.055
|
|
|
|
forebrain neuron differentiation
|
GO:0021879 |
52 |
0.055
|
|
|
|
neutral lipid metabolic process
|
GO:0006638 |
57 |
0.055
|
|
|
|
cellular macromolecule catabolic process
|
GO:0044265 |
206 |
0.054
|
|
|
|
keratinocyte proliferation
|
GO:0043616 |
21 |
0.054
|
|
|
|
negative regulation of protein phosphorylation
|
GO:0001933 |
126 |
0.054
|
|
|
|
cardiac pacemaker cell fate commitment
|
GO:0060927 |
1 |
0.053
|
|
|
|
wnt signaling pathway
|
GO:0016055 |
188 |
0.053
|
|
|
|
positive regulation of macrophage derived foam cell differentiation
|
GO:0010744 |
4 |
0.052
|
|
|
|
hormone mediated signaling pathway
|
GO:0009755 |
23 |
0.052
|
|
|
|
limb development
|
GO:0060173 |
166 |
0.052
|
|
|
|
renal vesicle induction
|
GO:0072034 |
3 |
0.052
|
|
|
|
cellular response to biotic stimulus
|
GO:0071216 |
92 |
0.052
|
|
|
|
regulation of innate immune response
|
GO:0045088 |
91 |
0.051
|
|
|
|
axon ensheathment
|
GO:0008366 |
76 |
0.051
|
|
|
|
regulation of peptidase activity
|
GO:0052547 |
96 |
0.051
|
|
|
|
regulation of cardioblast differentiation
|
GO:0051890 |
3 |
0.051
|
|
|
|
ventricular cardiac myofibril assembly
|
GO:0055005 |
3 |
0.051
|
|
|
|
store operated calcium entry
|
GO:0002115 |
7 |
0.051
|
|
|
|
negative regulation of nervous system development
|
GO:0051961 |
156 |
0.050
|
|
|
|
positive regulation of protein phosphorylation
|
GO:0001934 |
242 |
0.050
|
|
|
|
regulation of systemic arterial blood pressure by hormone
|
GO:0001990 |
25 |
0.050
|
|
|
|
regulation of erk1 and erk2 cascade
|
GO:0070372 |
71 |
0.050
|
|
|
|
regulation of renin secretion into blood stream
|
GO:1900133 |
4 |
0.050
|
|
|
|
blastocyst development
|
GO:0001824 |
80 |
0.050
|
|
|
|
positive regulation of protein kinase activity
|
GO:0045860 |
144 |
0.049
|
|
|
|
positive regulation of response to wounding
|
GO:1903036 |
66 |
0.049
|
|
|
|
regulation of systemic arterial blood pressure mediated by a chemical signal
|
GO:0003044 |
33 |
0.049
|
|
|
|
regulation of map kinase activity
|
GO:0043405 |
120 |
0.049
|
|
|
|
muscle system process
|
GO:0003012 |
141 |
0.049
|
|
|
|
multicellular organism growth
|
GO:0035264 |
161 |
0.048
|
|
|
|
regulation of proteolysis
|
GO:0030162 |
164 |
0.048
|
|
|
|
lipid homeostasis
|
GO:0055088 |
63 |
0.048
|
|
|
|
regulation of neuron differentiation
|
GO:0045664 |
281 |
0.047
|
|
|
|
antibacterial peptide production
|
GO:0002778 |
2 |
0.046
|
|
|
|
corticotropin releasing hormone secretion
|
GO:0043396 |
2 |
0.046
|
|
|
|
binding of sperm to zona pellucida
|
GO:0007339 |
34 |
0.046
|
|
|
|
cellular response to lipid
|
GO:0071396 |
145 |
0.046
|
|
|
|
cardiac muscle tissue morphogenesis
|
GO:0055008 |
44 |
0.046
|
|
|
|
purine containing compound metabolic process
|
GO:0072521 |
311 |
0.045
|
|
|
|
organic cyclic compound catabolic process
|
GO:1901361 |
295 |
0.045
|
|
|
|
ameboidal type cell migration
|
GO:0001667 |
128 |
0.045
|
|
|
|
kinin cascade
|
GO:0002254 |
2 |
0.045
|
|
|
|
ribose phosphate metabolic process
|
GO:0019693 |
291 |
0.045
|
|
|
|
defense response to gram positive bacterium
|
GO:0050830 |
50 |
0.045
|
|
|
|
antimicrobial peptide production
|
GO:0002775 |
2 |
0.045
|
|
|
|
sa node cell action potential
|
GO:0086015 |
4 |
0.045
|
|
|
|
regulation of endopeptidase activity
|
GO:0052548 |
89 |
0.045
|
|
|
|
blood circulation
|
GO:0008015 |
195 |
0.044
|
|
|
|
peptidyl tyrosine modification
|
GO:0018212 |
145 |
0.044
|
|
|
|
cellular chemical homeostasis
|
GO:0055082 |
215 |
0.044
|
|
|
|
atrioventricular node cell fate commitment
|
GO:0060929 |
1 |
0.044
|
|
|
|
negative regulation of epithelial cell proliferation
|
GO:0050680 |
64 |
0.043
|
|
|
|
connective tissue development
|
GO:0061448 |
179 |
0.043
|
|
|
|
ribose phosphate biosynthetic process
|
GO:0046390 |
59 |
0.042
|
|
|
|
atrioventricular node cell differentiation
|
GO:0060922 |
2 |
0.042
|
|
|
|
tissue homeostasis
|
GO:0001894 |
115 |
0.042
|
|
|
|
amine metabolic process
|
GO:0009308 |
45 |
0.042
|
|
|
|
protein ubiquitination
|
GO:0016567 |
171 |
0.042
|
|
|
|
respiratory system development
|
GO:0060541 |
190 |
0.042
|
|
|
|
positive regulation of programmed cell death
|
GO:0043068 |
218 |
0.042
|
|
|
|
cyclic nucleotide metabolic process
|
GO:0009187 |
59 |
0.042
|
|
|
|
regulation of transmembrane receptor protein serine threonine kinase signaling pathway
|
GO:0090092 |
112 |
0.041
|
|
|
|
determination of left right symmetry
|
GO:0007368 |
80 |
0.041
|
|
|
|
heterocycle catabolic process
|
GO:0046700 |
280 |
0.040
|
|
|
|
endocytosis
|
GO:0006897 |
168 |
0.040
|
|
|
|
forebrain generation of neurons
|
GO:0021872 |
63 |
0.040
|
|
|
|
negative regulation of hydrolase activity
|
GO:0051346 |
71 |
0.039
|
|
|
|
negative regulation of keratinocyte differentiation
|
GO:0045617 |
4 |
0.039
|
|
|
|
intestinal cholesterol absorption
|
GO:0030299 |
5 |
0.039
|
|
|
|
cholesterol homeostasis
|
GO:0042632 |
44 |
0.039
|
|
|
|
response to decreased oxygen levels
|
GO:0036293 |
59 |
0.039
|
|
|
|
habituation
|
GO:0046959 |
3 |
0.039
|
|
|
|
cellular response to molecule of bacterial origin
|
GO:0071219 |
83 |
0.039
|
|
|
|
sulfur compound biosynthetic process
|
GO:0044272 |
37 |
0.039
|
|
|
|
ribonucleoside metabolic process
|
GO:0009119 |
245 |
0.039
|
|
|
|
satellite cell activation involved in skeletal muscle regeneration
|
GO:0014901 |
3 |
0.039
|
|
|
|
regulation of antimicrobial humoral response
|
GO:0002759 |
3 |
0.039
|
|
|
|
homeostasis of number of cells
|
GO:0048872 |
210 |
0.038
|
|
|
|
water homeostasis
|
GO:0030104 |
27 |
0.038
|
|
|
|
nucleotide metabolic process
|
GO:0009117 |
332 |
0.038
|
|
|
|
purkinje myocyte differentiation
|
GO:0003168 |
1 |
0.038
|
|
|
|
regulation of satellite cell activation involved in skeletal muscle regeneration
|
GO:0014717 |
3 |
0.037
|
|
|
|
cardiac chamber morphogenesis
|
GO:0003206 |
93 |
0.037
|
|
|
|
hexose metabolic process
|
GO:0019318 |
98 |
0.037
|
|
|
|
lung epithelium development
|
GO:0060428 |
37 |
0.037
|
|
|
|
striated muscle cell proliferation
|
GO:0014855 |
39 |
0.037
|
|
|
|
defense response to bacterium
|
GO:0042742 |
119 |
0.037
|
|
|
|
positive regulation of voltage gated calcium channel activity
|
GO:1901387 |
2 |
0.037
|
|
|
|
cellular component assembly involved in morphogenesis
|
GO:0010927 |
139 |
0.037
|
|
|
|
antimicrobial peptide biosynthetic process
|
GO:0002777 |
2 |
0.037
|
|
|
|
carbohydrate metabolic process
|
GO:0005975 |
230 |
0.037
|
|
|
|
positive regulation of blood circulation
|
GO:1903524 |
22 |
0.037
|
|
|
|
intestinal absorption
|
GO:0050892 |
13 |
0.036
|
|
|
|
positive regulation of the force of heart contraction by chemical signal
|
GO:0003099 |
3 |
0.036
|
|
|
|
epithelial cell proliferation
|
GO:0050673 |
174 |
0.036
|
|
|
|
negative regulation of neuron projection development
|
GO:0010977 |
50 |
0.036
|
|
|
|
muscle tissue morphogenesis
|
GO:0060415 |
53 |
0.035
|
|
|
|
cellular response to amino acid stimulus
|
GO:0071230 |
29 |
0.035
|
|
|
|
carbohydrate homeostasis
|
GO:0033500 |
128 |
0.035
|
|
|
|
positive regulation of innate immune response
|
GO:0045089 |
80 |
0.035
|
|
|
|
intrinsic apoptotic signaling pathway
|
GO:0097193 |
132 |
0.035
|
|
|
|
atrioventricular node cell development
|
GO:0060928 |
2 |
0.035
|
|
|
|
regulation of antimicrobial peptide biosynthetic process
|
GO:0002805 |
1 |
0.034
|
|
|
|
divalent inorganic cation transport
|
GO:0072511 |
178 |
0.034
|
|
|
|
purine containing compound biosynthetic process
|
GO:0072522 |
70 |
0.034
|
|
|
|
g protein coupled receptor signaling pathway
|
GO:0007186 |
243 |
0.034
|
|
|
|
activation of immune response
|
GO:0002253 |
138 |
0.034
|
|
|
|
bone mineralization
|
GO:0030282 |
54 |
0.034
|
|
|
|
negative regulation of epidermal cell differentiation
|
GO:0045605 |
7 |
0.034
|
|
|
|
bone development
|
GO:0060348 |
120 |
0.034
|
|
|
|
positive regulation of cytokine production
|
GO:0001819 |
174 |
0.034
|
|
|
|
positive regulation of transferase activity
|
GO:0051347 |
167 |
0.034
|
|
|
|
regulation of action potential
|
GO:0098900 |
4 |
0.033
|
|
|
|
nucleic acid phosphodiester bond hydrolysis
|
GO:0090305 |
49 |
0.033
|
|
|
|
regulation of protein maturation
|
GO:1903317 |
96 |
0.033
|
|
|
|
regulation of blood pressure
|
GO:0008217 |
93 |
0.033
|
|
|
|
regulation of purine nucleotide metabolic process
|
GO:1900542 |
169 |
0.033
|
|
|
|
regulation of cellular ketone metabolic process
|
GO:0010565 |
66 |
0.033
|
|
|
|
ventral spinal cord interneuron fate determination
|
GO:0060580 |
1 |
0.033
|
|
|
|
diencephalon development
|
GO:0021536 |
63 |
0.033
|
|
|
|
embryonic organ morphogenesis
|
GO:0048562 |
276 |
0.033
|
|
|
|
pituitary gland development
|
GO:0021983 |
38 |
0.033
|
|
|
|
sodium ion transport
|
GO:0006814 |
73 |
0.032
|
|
|
|
establishment of skin barrier
|
GO:0061436 |
14 |
0.032
|
|
|
|
purine ribonucleotide biosynthetic process
|
GO:0009152 |
59 |
0.032
|
|
|
|
response to nutrient levels
|
GO:0031667 |
109 |
0.032
|
|
|
|
regulation of protein processing
|
GO:0070613 |
96 |
0.032
|
|
|
|
negative regulation of calcium ion transport
|
GO:0051926 |
9 |
0.032
|
|
|
|
regulation of fat cell differentiation
|
GO:0045598 |
81 |
0.032
|
|
|
|
nucleoside triphosphate metabolic process
|
GO:0009141 |
230 |
0.031
|
|
|
|
positive regulation of heart rate by epinephrine norepinephrine
|
GO:0001996 |
4 |
0.031
|
|
|
|
phospholipid metabolic process
|
GO:0006644 |
87 |
0.031
|
|
|
|
defense response to gram negative bacterium
|
GO:0050829 |
28 |
0.031
|
|
|
|
ventricular cardiac muscle tissue morphogenesis
|
GO:0055010 |
32 |
0.031
|
|
|
|
acute inflammatory response
|
GO:0002526 |
41 |
0.031
|
|
|
|
somatic stem cell maintenance
|
GO:0035019 |
47 |
0.030
|
|
|
|
ear morphogenesis
|
GO:0042471 |
118 |
0.030
|
|
|
|
positive regulation of gtp catabolic process
|
GO:0033126 |
85 |
0.030
|
|
|
|
regulation of calcium ion transport
|
GO:0051924 |
69 |
0.030
|
|
|
|
negative regulation of lymphocyte proliferation
|
GO:0050672 |
45 |
0.030
|
|
|
|
cellular metal ion homeostasis
|
GO:0006875 |
151 |
0.030
|
|
|
|
regulation of cell activation
|
GO:0050865 |
289 |
0.030
|
|
|
|
ventricular septum development
|
GO:0003281 |
42 |
0.030
|
|
|
|
positive regulation of cardioblast differentiation
|
GO:0051891 |
3 |
0.030
|
|
|
|
urogenital system development
|
GO:0001655 |
261 |
0.030
|
|
|
|
sympathetic neuron projection guidance
|
GO:0097491 |
4 |
0.029
|
|
|
|
neural tube patterning
|
GO:0021532 |
43 |
0.029
|
|
|
|
odontogenesis of dentin containing tooth
|
GO:0042475 |
66 |
0.029
|
|
|
|
lung morphogenesis
|
GO:0060425 |
50 |
0.029
|
|
|
|
regulation of antimicrobial peptide production
|
GO:0002784 |
1 |
0.029
|
|
|
|
endothelial cell migration
|
GO:0043542 |
44 |
0.029
|
|
|
|
positive regulation of lipid kinase activity
|
GO:0090218 |
11 |
0.029
|
|
|
|
trabecula formation
|
GO:0060343 |
24 |
0.029
|
|
|
|
pancreatic a cell fate commitment
|
GO:0003326 |
2 |
0.029
|
|
|
|
activation of innate immune response
|
GO:0002218 |
56 |
0.029
|
|
|
|
positive regulation of plasminogen activation
|
GO:0010756 |
2 |
0.029
|
|
|
|
brain renin angiotensin system
|
GO:0002035 |
5 |
0.028
|
|
|
|
regulation of water loss via skin
|
GO:0033561 |
16 |
0.028
|
|
|
|
operant conditioning
|
GO:0035106 |
2 |
0.028
|
|
|
|
inflammatory response
|
GO:0006954 |
244 |
0.028
|
|
|
|
positive regulation of epithelial cell proliferation
|
GO:0050679 |
68 |
0.028
|
|
|
|
bmp signaling pathway
|
GO:0030509 |
93 |
0.028
|
|
|
|
organic hydroxy compound transport
|
GO:0015850 |
93 |
0.028
|
|
|
|
positive regulation of keratinocyte proliferation
|
GO:0010838 |
4 |
0.028
|
|
|
|
epithelial cell migration
|
GO:0010631 |
63 |
0.028
|
|
|
|
regulation of lipid kinase activity
|
GO:0043550 |
14 |
0.028
|
|
|
|
regulation of striated muscle contraction
|
GO:0006942 |
25 |
0.028
|
|
|
|
regulation of membrane depolarization
|
GO:0003254 |
11 |
0.028
|
|
|
|
sulfur compound metabolic process
|
GO:0006790 |
100 |
0.028
|
|
|
|
fibrinolysis
|
GO:0042730 |
3 |
0.028
|
|
|
|
anatomical structure maturation
|
GO:0071695 |
49 |
0.028
|
|
|
|
regulation of serine type endopeptidase activity
|
GO:1900003 |
2 |
0.028
|
|
|
|
glucose homeostasis
|
GO:0042593 |
128 |
0.028
|
|
|
|
anatomical structure homeostasis
|
GO:0060249 |
145 |
0.028
|
|
|
|
myosin filament organization
|
GO:0031033 |
3 |
0.027
|
|
|
|
intestinal epithelial structure maintenance
|
GO:0060729 |
4 |
0.027
|
|
|
|
positive regulation of mapk cascade
|
GO:0043410 |
170 |
0.027
|
|
|
|
regulation of sodium ion transport
|
GO:0002028 |
29 |
0.027
|
|
|
|
regulation of hormone levels
|
GO:0010817 |
211 |
0.027
|
|
|
|
divalent metal ion transport
|
GO:0070838 |
172 |
0.027
|
|
|
|
digestive tract morphogenesis
|
GO:0048546 |
147 |
0.027
|
|
|
|
nucleobase containing small molecule metabolic process
|
GO:0055086 |
352 |
0.027
|
|
|
|
ribonucleotide biosynthetic process
|
GO:0009260 |
59 |
0.027
|
|
|
|
positive regulation of peptidyl tyrosine phosphorylation
|
GO:0050731 |
61 |
0.027
|
|
|
|
peptide biosynthetic process
|
GO:0043043 |
11 |
0.027
|
|
|
|
regulation of multi organism process
|
GO:0043900 |
111 |
0.027
|
|
|
|
neuroepithelial cell differentiation
|
GO:0060563 |
37 |
0.027
|
|
|
|
positive regulation of apoptotic process
|
GO:0043065 |
217 |
0.027
|
|
|
|
negative regulation of feeding behavior
|
GO:2000252 |
1 |
0.026
|
|
|
|
forebrain neuron development
|
GO:0021884 |
30 |
0.026
|
|
|
|
neurological system process involved in regulation of systemic arterial blood pressure
|
GO:0001976 |
18 |
0.026
|
|
|
|
mapk cascade
|
GO:0000165 |
281 |
0.026
|
|
|
|
wound healing
|
GO:0042060 |
157 |
0.026
|
|
|
|
nucleotide biosynthetic process
|
GO:0009165 |
78 |
0.026
|
|
|
|
cell fate commitment
|
GO:0045165 |
210 |
0.026
|
|
|
|
circadian rhythm
|
GO:0007623 |
114 |
0.026
|
|
|
|
methylation
|
GO:0032259 |
134 |
0.026
|
|
|
|
regulation of muscle system process
|
GO:0090257 |
80 |
0.025
|
|
|
|
gastrulation with mouth forming second
|
GO:0001702 |
29 |
0.025
|
|
|
|
tissue kallikrein kinin cascade
|
GO:0002255 |
1 |
0.025
|
|
|
|
hair cycle
|
GO:0042633 |
90 |
0.025
|
|
|
|
negative regulation of immune system process
|
GO:0002683 |
209 |
0.025
|
|
|
|
cell fate determination
|
GO:0001709 |
32 |
0.025
|
|
|
|
bone morphogenesis
|
GO:0060349 |
78 |
0.025
|
|
|
|
negative regulation of ion transport
|
GO:0043271 |
28 |
0.025
|
|
|
|
positive regulation of renal sodium excretion
|
GO:0035815 |
2 |
0.025
|
|
|
|
regulation of wound healing
|
GO:0061041 |
40 |
0.025
|
|
|
|
acid secretion
|
GO:0046717 |
33 |
0.025
|
|
|
|
neural tube development
|
GO:0021915 |
160 |
0.025
|
|
|
|
positive regulation of lipid metabolic process
|
GO:0045834 |
40 |
0.025
|
|
|
|
macromolecule methylation
|
GO:0043414 |
120 |
0.025
|
|
|
|
positive regulation of neuron differentiation
|
GO:0045666 |
141 |
0.024
|
|
|
|
glycoprotein metabolic process
|
GO:0009100 |
116 |
0.024
|
|
|
|
gastrin induced gastric acid secretion
|
GO:0001698 |
1 |
0.024
|
|
|
|
proepicardium development
|
GO:0003342 |
2 |
0.024
|
|
|
|
positive regulation of the force of heart contraction by epinephrine norepinephrine
|
GO:0001997 |
3 |
0.024
|
|
|
|
response to extracellular stimulus
|
GO:0009991 |
127 |
0.024
|
|
|
|
detection of stimulus
|
GO:0051606 |
84 |
0.024
|
|
|
|
glial cell development
|
GO:0021782 |
54 |
0.024
|
|
|
|
positive regulation of wound healing
|
GO:0090303 |
17 |
0.024
|
|
|
|
regulation of response to wounding
|
GO:1903034 |
189 |
0.024
|
|
|
|
regulation of reproductive process
|
GO:2000241 |
66 |
0.024
|
|
|
|
type ii pneumocyte differentiation
|
GO:0060510 |
7 |
0.024
|
|
|
|
stem cell differentiation
|
GO:0048863 |
268 |
0.024
|
|
|
|
cell communication by electrical coupling involved in cardiac conduction
|
GO:0086064 |
2 |
0.024
|
|
|
|
negative regulation of protein maturation
|
GO:1903318 |
79 |
0.023
|
|
|
|
positive regulation of defense response
|
GO:0031349 |
124 |
0.023
|
|
|
|
male gamete generation
|
GO:0048232 |
285 |
0.023
|
|
|
|
nitric oxide mediated signal transduction
|
GO:0007263 |
4 |
0.023
|
|
|
|
peptide transport
|
GO:0015833 |
133 |
0.023
|
|
|
|
glycosyl compound catabolic process
|
GO:1901658 |
206 |
0.023
|
|
|
|
positive regulation of secretion
|
GO:0051047 |
130 |
0.023
|
|
|
|
camera type eye development
|
GO:0043010 |
266 |
0.023
|
|
|
|
regulation of apoptotic signaling pathway
|
GO:2001233 |
197 |
0.023
|
|
|
|
regulation of biomineral tissue development
|
GO:0070167 |
33 |
0.023
|
|
|
|
extracellular matrix organization
|
GO:0030198 |
147 |
0.023
|
|
|
|
negative regulation of t cell mediated immunity
|
GO:0002710 |
9 |
0.023
|
|
|
|
bradykinin biosynthetic process
|
GO:0002936 |
1 |
0.023
|
|
|
|
mesenchymal cell differentiation involved in lung development
|
GO:0060915 |
2 |
0.023
|
|
|
|
positive regulation of activation of membrane attack complex
|
GO:0001970 |
2 |
0.023
|
|
|
|
forebrain morphogenesis
|
GO:0048853 |
17 |
0.023
|
|
|
|
negative regulation of cell cycle
|
GO:0045786 |
123 |
0.023
|
|
|
|
multicellular organismal homeostasis
|
GO:0048871 |
164 |
0.023
|
|
|
|
cation transport
|
GO:0006812 |
399 |
0.022
|
|
|
|
lipid localization
|
GO:0010876 |
126 |
0.022
|
|
|
|
blood vessel morphogenesis
|
GO:0048514 |
285 |
0.022
|
|
|
|
protein kinase c activating g protein coupled receptor signaling pathway
|
GO:0007205 |
4 |
0.022
|
|
|
|
astrocyte fate commitment
|
GO:0060018 |
4 |
0.022
|
|
|
|
molting cycle
|
GO:0042303 |
90 |
0.022
|
|
|
|
epithelium migration
|
GO:0090132 |
63 |
0.022
|
|
|
|
biomineral tissue development
|
GO:0031214 |
64 |
0.022
|
|
|
|
stem cell development
|
GO:0048864 |
219 |
0.022
|
|
|
|
cellular response to cytokine stimulus
|
GO:0071345 |
189 |
0.022
|
|
|
|
organophosphate catabolic process
|
GO:0046434 |
232 |
0.022
|
|
|
|
oligodendrocyte differentiation
|
GO:0048709 |
53 |
0.022
|
|
|
|
atrial cardiac muscle cell differentiation
|
GO:0055011 |
2 |
0.022
|
|
|
|
negative regulation of mesenchymal cell apoptotic process involved in nephron morphogenesis
|
GO:0072040 |
4 |
0.022
|
|
|
|
regulation of transcription from rna polymerase iii promoter
|
GO:0006359 |
2 |
0.022
|
|
|
|
activation of mapk activity
|
GO:0000187 |
59 |
0.022
|
|
|
|
fucosylation
|
GO:0036065 |
9 |
0.022
|
|
|
|
organ growth
|
GO:0035265 |
117 |
0.022
|
|
|
|
salivary gland development
|
GO:0007431 |
37 |
0.022
|
|
|
|
negative regulation of serotonin secretion
|
GO:0014063 |
2 |
0.022
|
|
|
|
determination of heart left right asymmetry
|
GO:0061371 |
48 |
0.022
|
|
|
|
positive regulation of cytosolic calcium ion concentration involved in phospholipase c activating g protein coupled signaling pathway
|
GO:0051482 |
4 |
0.021
|
|
|
|
cellular homeostasis
|
GO:0019725 |
240 |
0.021
|
|
|
|
spinal cord oligodendrocyte cell differentiation
|
GO:0021529 |
3 |
0.021
|
|
|
|
regulation of blood vessel size
|
GO:0050880 |
56 |
0.021
|
|
|
|
pancreatic pp cell differentiation
|
GO:0003312 |
2 |
0.021
|
|
|
|
regulation of phosphatidylinositol 3 kinase activity
|
GO:0043551 |
14 |
0.021
|
|
|
|
positive regulation of hydrolase activity
|
GO:0051345 |
148 |
0.021
|
|
|
|
gastric acid secretion
|
GO:0001696 |
6 |
0.021
|
|
|
|
sterol metabolic process
|
GO:0016125 |
58 |
0.021
|
|
|
|
regulation of protein serine threonine kinase activity
|
GO:0071900 |
157 |
0.021
|
|
|
|
response to alkaloid
|
GO:0043279 |
34 |
0.021
|
|
|
|
negative regulation of t cell proliferation
|
GO:0042130 |
38 |
0.021
|
|
|
|
organic anion transport
|
GO:0015711 |
137 |
0.021
|
|
|
|
response to organic cyclic compound
|
GO:0014070 |
198 |
0.021
|
|
|
|
negative regulation of peptidyl tyrosine phosphorylation
|
GO:0050732 |
17 |
0.021
|
|
|
|
regulation of transcription involved in cell fate commitment
|
GO:0060850 |
15 |
0.021
|
|
|
|
pancreatic pp cell fate commitment
|
GO:0003329 |
2 |
0.021
|
|
|
|
covalent chromatin modification
|
GO:0016569 |
163 |
0.021
|
|
|
|
cation transmembrane transport
|
GO:0098655 |
266 |
0.021
|
|
|
|
synaptic transmission
|
GO:0007268 |
329 |
0.021
|
|
|
|
type b pancreatic cell fate commitment
|
GO:0003327 |
1 |
0.021
|
|
|
|
digestive tract development
|
GO:0048565 |
190 |
0.021
|
|
|
|
purine nucleotide metabolic process
|
GO:0006163 |
302 |
0.021
|
|
|
|
artery development
|
GO:0060840 |
53 |
0.021
|
|
|
|
glial cell fate commitment
|
GO:0021781 |
14 |
0.021
|
|
|
|
regulation of system process
|
GO:0044057 |
200 |
0.020
|
|
|
|
regulation of carbohydrate metabolic process
|
GO:0006109 |
75 |
0.020
|
|
|
|
placenta development
|
GO:0001890 |
140 |
0.020
|
|
|
|
protein alkylation
|
GO:0008213 |
81 |
0.020
|
|
|
|
pulmonary myocardium development
|
GO:0003350 |
3 |
0.020
|
|
|
|
multi multicellular organism process
|
GO:0044706 |
109 |
0.020
|
|
|
|
posttranscriptional regulation of gene expression
|
GO:0010608 |
155 |
0.020
|
|
|
|
lung cell differentiation
|
GO:0060479 |
30 |
0.020
|
|
|
|
regeneration
|
GO:0031099 |
38 |
0.020
|
|
|
|
negative regulation of transmembrane transport
|
GO:0034763 |
15 |
0.020
|
|
|
|
regulation of osteoblast differentiation
|
GO:0045667 |
67 |
0.020
|
|
|
|
regulation of myelination
|
GO:0031641 |
20 |
0.020
|
|
|
|
chondrocyte differentiation
|
GO:0002062 |
72 |
0.020
|
|
|
|
mesenchymal cell apoptotic process involved in nephron morphogenesis
|
GO:1901145 |
4 |
0.020
|
|
|
|
cyclic nucleotide biosynthetic process
|
GO:0009190 |
44 |
0.020
|
|
|
|
nucleotide catabolic process
|
GO:0009166 |
217 |
0.020
|
|
|
|
cell recognition
|
GO:0008037 |
83 |
0.020
|
|
|
|
cellular response to acid chemical
|
GO:0071229 |
68 |
0.020
|
|
|
|
camp metabolic process
|
GO:0046058 |
40 |
0.020
|
|
|
|
telencephalon cell migration
|
GO:0022029 |
55 |
0.020
|
|
|
|
glycosyl compound metabolic process
|
GO:1901657 |
246 |
0.020
|
|
|
|
trabecula morphogenesis
|
GO:0061383 |
40 |
0.020
|
|
|
|
morphogenesis of a branching structure
|
GO:0001763 |
203 |
0.020
|
|
|
|
lipid catabolic process
|
GO:0016042 |
69 |
0.020
|
|
|
|
plasma cell differentiation
|
GO:0002317 |
3 |
0.019
|
|
|
|
ventricular cardiac muscle tissue development
|
GO:0003229 |
38 |
0.019
|
|
|
|
regulation of organ morphogenesis
|
GO:2000027 |
144 |
0.019
|
|
|
|
cardiocyte differentiation
|
GO:0035051 |
87 |
0.019
|
|
|
|
regulation of circadian rhythm
|
GO:0042752 |
58 |
0.019
|
|
|
|
negative regulation of behavior
|
GO:0048521 |
14 |
0.019
|
|
|
|
glandular epithelial cell differentiation
|
GO:0002067 |
38 |
0.019
|
|
|
|
regulation of cell projection organization
|
GO:0031344 |
206 |
0.019
|
|
|
|
purine ribonucleoside triphosphate catabolic process
|
GO:0009207 |
199 |
0.019
|
|
|
|
cell cell recognition
|
GO:0009988 |
44 |
0.019
|
|
|
|
response to endoplasmic reticulum stress
|
GO:0034976 |
53 |
0.019
|
|
|
|
prostate gland morphogenesis
|
GO:0060512 |
32 |
0.019
|
|
|
|
positive regulation of proteolysis
|
GO:0045862 |
85 |
0.019
|
|
|
|
lung epithelial cell differentiation
|
GO:0060487 |
29 |
0.019
|
|
|
|
negative regulation of peptidase activity
|
GO:0010466 |
46 |
0.019
|
|
|
|
purine ribonucleotide metabolic process
|
GO:0009150 |
290 |
0.019
|
|
|
|
cellular carbohydrate metabolic process
|
GO:0044262 |
119 |
0.019
|
|
|
|
regulation of peptide hormone secretion
|
GO:0090276 |
75 |
0.019
|
|
|
|
nucleoside phosphate catabolic process
|
GO:1901292 |
222 |
0.019
|
|
|
|
cardiac ventricle development
|
GO:0003231 |
83 |
0.018
|
|
|
|
phospholipase c activating serotonin receptor signaling pathway
|
GO:0007208 |
1 |
0.018
|
|
|
|
nucleoside phosphate metabolic process
|
GO:0006753 |
338 |
0.018
|
|
|
|
embryonic placenta development
|
GO:0001892 |
98 |
0.018
|
|
|
|
cardiac muscle tissue growth
|
GO:0055017 |
37 |
0.018
|
|
|
|
myoblast proliferation
|
GO:0051450 |
11 |
0.018
|
|
|
|
septum primum development
|
GO:0003284 |
4 |
0.018
|
|
|
|
regulation of cell motility
|
GO:2000145 |
236 |
0.018
|
|
|
|
protein activation cascade
|
GO:0072376 |
19 |
0.018
|
|
|
|
negative regulation of proteolysis
|
GO:0045861 |
74 |
0.018
|
|
|
|
rhythmic process
|
GO:0048511 |
174 |
0.018
|
|
|
|
anion transport
|
GO:0006820 |
177 |
0.018
|
|
|
|
labyrinthine layer development
|
GO:0060711 |
49 |
0.018
|
|
|
|
regulation of chromosome organization
|
GO:0033044 |
83 |
0.018
|
|
|
|
segmentation
|
GO:0035282 |
93 |
0.018
|
|
|
|
regulation of nucleotide metabolic process
|
GO:0006140 |
169 |
0.018
|
|
|
|
cell differentiation in spinal cord
|
GO:0021515 |
53 |
0.018
|
|
|
|
forebrain development
|
GO:0030900 |
302 |
0.018
|
|
|
|
branching involved in mammary gland duct morphogenesis
|
GO:0060444 |
27 |
0.018
|
|
|
|
multicellular organismal water homeostasis
|
GO:0050891 |
23 |
0.018
|
|
|
|
negative regulation of cell activation
|
GO:0050866 |
111 |
0.018
|
|
|
|
carbohydrate derivative catabolic process
|
GO:1901136 |
231 |
0.018
|
|
|
|
cellular response to abiotic stimulus
|
GO:0071214 |
56 |
0.017
|
|
|
|
regulation of protein binding
|
GO:0043393 |
60 |
0.017
|
|
|
|
nucleoside phosphate biosynthetic process
|
GO:1901293 |
79 |
0.017
|
|
|
|
cell substrate adhesion
|
GO:0031589 |
130 |
0.017
|
|
|
|
limbic system development
|
GO:0021761 |
72 |
0.017
|
|
|
|
central nervous system neuron differentiation
|
GO:0021953 |
162 |
0.017
|
|
|
|
formation of anatomical boundary
|
GO:0048859 |
6 |
0.017
|
|
